Rofecoxib, a New Cyclooxygenase 2 Inhibitor, Shows Sustained Efficacy, Comparable With Other Nonsteroidal Anti-inflammatory Drugs: A 6-Week and a 1-Year Trial in Patients With Osteoarthritis
- 1 November 2000
- journal article
- Published by CLOCKSS Archive in Archives of Family Medicine
- Vol. 9 (10) , 1124-1134
- https://doi.org/10.1001/archfami.9.10.1124